Dr. Erica D. Farrand, MD

Dr. Farrand practices at UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health.

Dr. Farrand's NPI, 1518284959, was assigned on April 26, 2010. Dr. Farrand graduated from Vagelos College of Physicians and Surgeons in 2010. Dr. Farrand's New York license number on file is 267255.

Dr. Farrand's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights, at 505 Parnassus Ave, Box 0296, San Francisco, CA 94143 in San Francisco County. The practice phone is (415) 353-2733.

Dr. Farrand's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health. The medical group on file is UCSF Pediatrics. Dmand AI also links Dr. Farrand to 4 more medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Farrand practices, 2 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Farrand's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Farrand is board certified in critical care medicine by the American Board of Internal Medicine. Dmand AI has Dr. Farrand's licenses on file in 2 states: New York and California.

Dmand AI lists chronic lung disease, chronic obstructive pulmonary disease (COPD), chronic respiratory failure and pulmonary fibrosis among the conditions Dr. Farrand treats.

CMS data shows 216 Medicare services from Dr. Farrand across 7 procedure codes in 2024, for 123 Medicare patients. Medicare paid $19,528 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 123 Medicare patients who saw Dr. Farrand in 2024. The largest group is 65 to 74, with 49 patients. 75% of them have high blood pressure, and 72% have high cholesterol. 33% are also on Medicaid. Their average risk score is 3.02, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Farrand's median patient age at 71, with 48% women.

In 2024, Dr. Farrand wrote 193 Medicare Part D claims for 33 patients. 53% of them were for generic drugs. CMS names the drug for 171 of them, across 5 drugs with 11 or more claims each, at $1,077,816 in total drug cost. In 2023, CMS named 146 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Farrand for performance year 2024, reported as part of a group. Dr. Farrand accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Farrand as offering telehealth.

Dmand AI links 22 papers to Dr. Farrand, published from 2012 to 2025. 2020 was the busiest year, with 3. The most frequent topics are Idiopathic Pulmonary Fibrosis, Lung Diseases, Interstitial and Adrenal Cortex Hormones. Dr. Farrand has published most often in Chest. Dr. Farrand's most frequent co-authors are Harold R. Collard, MD, Kerri Johannson, MD and Brett James Ley, MD.

CMS Open Payments shows 23 general payments to Dr. Farrand from 1 drug or device company from 2022 to 2025. Consulting fees make up the largest share, 77% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $14,901.

Dmand AI lists 1 award for Dr. Farrand, most recently NCQA PCMH in 2016.

Dr. Farrand graduated from Vagelos College of Physicians and Surgeons in 2010.

Dr. Farrand is in network with 6 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.